16 April 2025, Geneva – The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA), representing the innovative pharmaceutical industry worldwide, and the European Confederation of Pharmaceutical Entrepreneurs (EUCOPE), representing small and mid-sized innovative health technology companies in Europe, welcome and echo the Call… read more
Brussels, 8 April, 2025 – This morning, EUCOPE’s Secretary General, Dr Alexander Natz, joined the European Commission’s Strategic Dialogue with the pharmaceutical sector. We thank Commission President von der Leyen for convening this meeting as an important opportunity to share the perspective of the innovative… read more
Brussels, 10 March – A coalition of 39 leading representatives from the European health community has published a joint statement welcoming the publication of the European Health Data Space (EHDS) regulation in the EU’s Official Journal. The group underscores the need to promptly establish an… read more
Sounds of Science – episode 20 Tackling Medicine Shortages: the role of EU Policies Medicine shortages are a growing challenge across Europe, impacting patients, healthcare systems, and companies alike. But how is the EU tackling this issue? What role do EU policies and the upcoming… read more
EUCOPE’s Sounds of Science Podcast – Episode 19 Building a competitive pharmaceutical ecosystem: EUCOPE’s call to EU Institutions In this episode of Sounds of Science, we invited our members, Toon Digneffe and Enrico Piccinini, to discuss with Alexander Natz how the EU’s competitiveness strategies may… read more
Regularly, EUCOPE spotlights a member company and the great work it’s doing to advance the life sciences industry and drive innovation to serve patients better. For the December edition, we spoke with Catherine Owen Adams, CEO of Acadia Pharmaceuticals. Tell us about your organization and… read more
On November 14th, EUCOPE together with FTI Consulting EU hosted the event “What Drives Life Sciences Investment in the EU and the Future Impact of the Pharma Package”, to mark the launch of the report, ‘’The Economic Lens: Understanding What Makes the EU Attractive for… read more
ARM, EFPIA, EUCOPE, EuropaBio, Vaccines Europe From 12 January 2025 the Regulation (EU) 2021/2282 on health technology assessment will apply and the first Joint Clinical Assessments (JCA) will be performed to assess the relative clinical effectiveness of new innovative cancer therapies and cell and gene… read more
A new college of Commissioners All signs point towards the need for a more competitive environment for pharmaceutical R&D in Europe. In this context, EUCOPE extends its congratulations to the newly appointed European Commissioners, whose mandates will deliver on large-scale change initiated under the last… read more
Regularly, EUCOPE spotlights a member company and the great work it’s doing to advance the life sciences industry and drive innovation to serve patients better. For the November edition, we spoke with Adam Parnaby, Senior Director, Market Access Policy, Europe, Bristol Myers Squibb. Tell us… read more
Keep up-to-date on all of the most pertinent policy files and regulatory news around the world of European health technologies with our monthly newsletter – the Innovation Eye-View
You are currently viewing a placeholder content from Facebook. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
You are currently viewing a placeholder content from Instagram. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
You are currently viewing a placeholder content from X. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.